首页    期刊浏览 2024年11月28日 星期四
登录注册

文章基本信息

  • 标题:FR901724, a Novel Anti-human Immunodeficiency Virus (HIV) Peptide Produced by Streptomyces, Shows Synergistic Antiviral Activities with HIV Protease Inhibitor and 2', 3'-Dideoxynucleosides
  • 本地全文:下载
  • 作者:Hideki NAKASHIMA ; Kohji ICHIYAMA ; Kazuhiko INAZAWA
  • 期刊名称:Biological and Pharmaceutical Bulletin
  • 印刷版ISSN:0918-6158
  • 电子版ISSN:1347-5215
  • 出版年度:1996
  • 卷号:19
  • 期号:3
  • 页码:405-412
  • DOI:10.1248/bpb.19.405
  • 出版社:The Pharmaceutical Society of Japan
  • 摘要:A novel tricyclic 21-amino-acid peptide, FR901724, was isolated from the cultured broth of Streptomyces sp. No. 73264. This peptide appears to possess potent anti-human immunodeficiency virus (HIV) activity in vitro and might represent a lead to a new class of anti-HIV agents ; it qualifies as an HIV-cell fusion inhibitor because of its weak inhibition of virus-cell binding and strong inhibition of syncytium formation. From the time-of-addition experiments, the mode of action of FR901724 was found to definitely differ from that of KNI-272, a peptide mimetic allophenylnorstatine-derivative HIV protease inhibitor. FR901724 appears to interact with a stage of the virus replicative cycle that may well correspond to virus-cell fusion. We also found that FR901724 was synergistic or had a strong tendency toward synergism when combined with other antiviral drugs, such as KNI-272, AZT, ddI and dextran sulfate.
  • 关键词:AIDS;anti-HIV compound;protease inhibitor;dideoxynucleoside;drug combination
国家哲学社会科学文献中心版权所有